Search Results - "Cubedo, R"

Cancer antigen 125 associated with multiple benign and malignant pathologies by Miralles, C, Orea, M, España, P, Provencio, M, Sánchez, A, Cantos, B, Cubedo, R, Carcereny, E, Bonilla, F, Gea, T

“…Cancer antigen (CA) 125 tumor-associated antigen is a high molecular glycoprotein used for follow-up of epithelial ovarian cancer. The test is often requested…”
Get full text

Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study by Martín-Liberal, J., López-Pousa, A., Broto, J. Martín, Cubedo, R., Gallego, O., Brendel, E., Tirado, O. M., del Muro, X. García

“…Summary Background This phase I trial assessed safety, pharmacokinetics (PK), dose limiting toxicity (DLT), maximum tolerated dose and recommended dose (RD) of…”
Get full text

Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM) by Colomer, R., Alba, E., González-Martin, A., Paz-Ares, L., Martín, M., Llombart, A., Rodríguez Lescure, Á., Salvador, J., Albanell, J., Isla, D., Lomas, M., Rodríguez, C.A., Trigo, J.M., Germà, J.R., Bellmunt, J., Tabernero, J., Rosell, R., Aranda, E., Cubedo, R., Baselga, J.

“…Cancer treatment involves the participation of multiple medical specialties and, as our knowledge of the disease increases, this fact becomes even more…”
Get full text

Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS study by Fuster, D, Ayuso, J R, Poveda, A, Cubedo, R, Casado, A, Martínez-Trufero, J, López-Pousa, A, Del Muro, X G, Lomeña, F, Maurel, J, Pons, F

“…The aim of this study was to evaluate the utility of positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) in monitoring response in refractory…”
Get full text

Propofol versus midazolam : Safety and efficacy for sedating the severe trauma patient by SANCHEZ-IZQUIERDO-RIERA, J. A, CABALLERO-CUBEDO, R. E, PEREZ-VELA, J. L, AMBROS-CHECA, A, CANTALAPIEDRA-SANTIAGO, J. A, ALTED-LOPEZ, E

“…Previous studies have compared sedation profiles with midazolam (Mz) and propofol (Pf), particularly in heterogeneous populations of patients. Decreases in…”
Get full text

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors by Mayordomo, J I, Rivera, F, Díaz-Puente, M T, Lianes, P, Colomer, R, López-Brea, M, López, E, Paz-Ares, L, Hitt, R, García-Ribas, I

“…Several randomized trials have tested the use of granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in…”
Get more information

Tratamiento del osteosarcoma. Revisión by Majó, J, Cubedo, R, Pardo, N

“…Resumen Se presenta una actualización del tratamiento del osteosarcoma convencional, con exclusión de las formas secundarias por malignización de otras…”
Get full text

6027 POSTER Are there variations in the cause of deaths over different time periods in Hodgkin's disease? by Cantos, B, Hurtado, A, Maximiano, C, Mellor, S, Manquillo, A, Espinosa, P, Mendez, M, Cubedo, R, Provencio, P

Get full text

2105 POSTER An accelerated loading regimen for trastuzumab leads to early higher than steady-state serum concentrations by Leyland-Jones, B, Colomer, R, Trudeau, M, Wardley, A, Latreille, J, Cameron, D, Cubedo, R, Al-Sakaff, N, Charoin, J.E, Cortés, J

Get full text

Neuroleptic malignant syndrome in a patient with head injury by PEREZ-VELA, J. L, SANCHEZ CASADO, M, SANCHEZ-IZQUIERDO RIERA, J. A, AMBROS CHECA, A, CABALLERO CUBEDO, R, ALTED LOPEZ, E

“…Neuroleptic malignant syndrome is an idiosyncratic reaction associated with the use of neuroleptic drugs. We report a case of this rare syndrome in a head…”
Get full text

Metastasis from choriocarcinoma of the mediastinum producing acute appendicitis by RAMIA, J. M, ALCALDE, J, DHIMES, P, CUBEDO, R

Get full text

1416PDINTEGRATING GENOTYPE IN RISK CLASSIFICATION FOR GIST RECURRENCE. A SPANISH GROUP FOR SARCOMA RESEARCH (GEIS) STUDY by Martin Broto, J., Calabuig, S., Rubio, J., Gutierrez, A., Duran, J., Garcia, F., Martinez-Trufero, J., Maurel, J., García Del Muro, X., Cruz, J., Cubedo, R., Poveda, A.M., Valverde Morales, C., De Sande González, L.M., De Juan, A., Lopez-Guerrero, J.A.

“…Abstract Aim: Relevant prognostic factors for relapse free survival (RFS) in GIST relies on clinical and pathologic variables as size, mitoses, location or…”
Get full text

Integrating Genotype in Risk Classification for Gist Recurrence. a Spanish Group for Sarcoma Research (Geis) Study by Martin Broto, J., Calabuig, S., Rubio, J., Gutierrez, A., Duran, J., Garcia, F., Martinez-Trufero, J., Maurel, J., García Del Muro, X., Cruz, J., Cubedo, R., Poveda, A.M., Valverde Morales, C., De Sande González, L.M., De Juan, A., Lopez-Guerrero, J.A.

Get full text

1517TiP - Randomized, Open, Prospective, Phase II Clinical Trial of Doxorubicin (DOXO) vs. Trabectedin Plus Doxo in the First-Line Treatment of Patients (PTS) with Advanced Non-Operable and/or Metastatic Soft Tissue Sarcomas (STS): Geis-20 Study by Broto, J. Martin, Del Muro, X. Garcia, Lopez-Pousa, A., De Penas, R. Las, Maurel, J., Cubedo, R., Redondo, A., Martinez-Trufero, J., Jurado, J. Cruz, Poveda, A.M.

“…Advanced STS are rare diseases that need development of efficacious new treatments, as exemplified by doxorubicin still being the reference standard after 30…”
Get full text

Randomized, Open, Prospective, Phase II Clinical Trial of Doxorubicin (DOXO) vs. Trabectedin Plus Doxo in the First-Line Treatment of Patients (PTS) with Advanced Non-Operable and/or Metastatic Soft Tissue Sarcomas (STS): Geis-20 Study by Broto, J. Martin, Del Muro, X. Garcia, Lopez-Pousa, A., De Penas, R. Las, Maurel, J., Cubedo, R., Redondo, A., Martinez-Trufero, J., Jurado, J. Cruz, Poveda, A.M.

Get full text

Phase I study of sorafenib plus ifosfamide in patients with advanced soft tissue and bone sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study by Garcia del Muro, X., Lopez-Pousa, A., Martin Broto, J., Cubedo, R., Jimenez Colomo, L., Gallego, O., Provencio-Pulla, M.

“…Abstract only…”
Get full text

A phase II study of a new formulation of nonpegylated liposomal doxorubicin (doxorubicin GP-pharm) as first-line treatment in patients with advanced soft-tissue sarcomas (STS) who are age 65 or older: A GEIS trial by Lopez-Pousa, A., Bui Nguyen, B., Garcia del Muro, X., Martin Broto, J., Balañá, C., Lavernia, J., Cruz, J., Maurel, J., Andres, R., Valverde, C. M., Fra, J., Martinez-Trufero, J., Lopez-Martin, J. A., Sevilla, I., Cubedo, R., Blay, J.

“…Abstract only…”
Get full text

KIT, DOG1, PDGFR , and IGFR1 gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients by Martin Broto, J., Garcia del Muro, X., Gutierrez, A., Martinez-Trufero, J., Serrano, T., Rubió, J., Lainez, N., Sevilla, I., Cruz, J., Ramos, R., Ortega, L., Poveda, A., Ramirez, M., Cubedo, R., Lopez-Guerrero, J.

“…Abstract only…”
Get full text

Late relapses in Hodgkin's disease by Provencio-Pulla, M., Sánchez, A., Cantos, B., Gasent Blesa, J., Mendez, M., Maximiano, C., Cubedo, R., Bonilla, F., Galan, L., Huelves, M.

“…Abstract only…”
Get full text

Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy by Manso, L, Ciruelos, E, Codes, M, De la Haba, J, Galan, A, Baena, J, Jaen, A, Gil, M, Murias, A, Blancas, I, Gonzalez, E, Perez, D, Bayo, JL, Mel, J, Garcia-Martinez, E, Cubedo, R, Salvador, J

Get full text